GAL and cancer: This study demonstrates the relationship between high expression of Gal-1 in cancer tissue and a poor OS in cancerous patients with obvious statistical heterogeneity (HR = 1.79, 95% CI 1.54–2.08, P < 0.001; I2 = 43.6%, P = 0.025).